Cleave Biosciences Lands $10,000,000 Series A Financing Round

  • Feed Type
  • Date
    4/9/2013
  • Company Name
    Cleave Biosciences
  • Mailing Address
    866 Malcolm Burlingame, CA 94010
  • Company Description
    The big idea at Cleave is to develop small-molecule chemical compounds that will interact with certain protein pathways that get thrown out of whack in patients with cancer.
  • Website
    http://www.cleavebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Cleave will use the funds to move its lead program into clinical trials and advance its second discovery program.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates

By posting a comment, you agree to our terms and conditions.